8000/0,"Neoplasm, benign"
8000/1,"Neoplasm, uncertain whether benign or malignant"
8000/2,"Neoplasm, in situ"
8000/3,"Neoplasm, malignant"
8000/6,"Neoplasm, metastatic"
8000/9,"Neoplasm, malignant, uncertain whether primary or metastatic"
8001/0,"Tumor cells, benign"
8001/1,"Tumor cells, uncertain whether benign or malignant"
8001/3,"Tumor cells, malignant"
8002/3,"Malignant tumor, small cell type"
8003/3,"Malignant tumor, giant cell type"
8004/3,"Malignant tumor, spindle cell type"
8005/0,"Clear cell tumor, NOS"
8005/3,"Malignant tumor, clear cell type"
8010/0,"Epithelial tumor, benign"
8010/2,"Carcinoma in situ, NOS"
8010/3,"Carcinoma, NOS"
8010/9,Carcinomatosis
8011/0,"Epithelioma, benign"
8011/2,"Epithelioma, in situ"
8011/3,"Epithelioma, malignant"
8012/3,"Large cell carcinoma, NOS"
8013/3,Large cell neuroendocrine carcinoma
8014/3,Large cell carcinoma with rhabdoid phenotype
8015/3,Glassy cell carcinoma
8020/3,"Carcinoma, undifferentiated, NOS"
8021/3,"Carcinoma, anaplastic, NOS"
8022/3,Pleomorphic carcinoma
8030/3,Giant cell and spindle cell carcinoma
8031/2,Giant cell carcinoma in situ
8031/3,Giant cell carcinoma
8032/3,"Spindle cell carcinoma, NOS"
8033/3,Pseudosarcomatous carcinoma
8034/3,Polygonal cell carcinoma
8035/3,Carcinoma with osteoclast-like giant cells
8040/0,"Tumorlet, benign"
8040/1,"Tumorlet, NOS"
8040/3,"Tumorlet, malignant"
8041/3,"Small cell carcinoma, NOS"
8042/2,Oat cell carcinoma in situ (C34._)
8042/3,Oat cell carcinoma (C34._)
8046/3,Non-small cell carcinoma (C34._)
8050/2,Papillary carcinoma in situ
8050/3,"Papillary carcinoma, NOS"
8051/0,Verrucous papilloma
8051/2,Verrucous carcinoma in situ
8052/0,"Squamous cell papilloma, NOS"
8052/2,"Papillary squamous cell carcinoma, non-invasive"
8052/3,Papillary squamous cell carcinoma
8053/0,"Squamous cell papilloma, inverted"
8053/3,"Squamous cell papilloma, inverted, malignant"
8060/0,Squamous papillomatosis
8070/2,"Squamous cell carcinoma in situ, NOS"
8070/3,"Squamous cell carcinoma, NOS"
8070/6,"Squamous cell carcinoma, metastatic, NOS"
8071/3,"Squamous cell carcinoma, keratinizing, NOS"
8072/2,"Squamous cell carcinoma, large cell, nonkeratinizing, in situ"
8072/3,"Squamous cell carcinoma, large cell, nonkeratinizing, NOS"
8073/2,"Squamous cell carcinoma, small cell, nonkeratinizing, in situ"
8073/3,"Squamous cell carcinoma, small cell, nonkeratinizing"
8074/2,"Squamous cell carcinoma, spindle cell, in situ"
8074/3,"Squamous cell carcinoma, spindle cell"
8075/2,"Squamous cell carcinoma, adenoid, in situ"
8075/3,"Squamous cell carcinoma, adenoid"
8076/3,"Squamous cell carcinoma, micro-invasive (C53._)"
8078/3,Squamous cell carcinoma with horn formation
8080/2,Queyrat erythroplasia (C60._)
8080/3,"Queyrat erythroplasia, malignant (C60._)"
8081/2,Bowen disease (C44._)
8082/2,Lymphoepithelial carcinoma in situ
8082/3,Lymphoepithelial carcinoma
8083/2,Basaloid squamous cell carcinoma in situ
8083/3,Basaloid squamous cell carcinoma
8084/3,"Squamous cell carcinoma, clear cell type"
8090/1,Basal cell tumor (C44._)
8090/2,Basal cell carcinoma in situ (C44._)
8090/3,"Basal cell carcinoma, NOS (C44._)"
8091/2,"Multicentric basal cell carcinoma, in situ (C44._)"
8092/3,"Infiltrating basal cell carcinoma, NOS (C44._)"
8093/3,"Basal cell carcinoma, fibroepithelial (C44._)"
8094/2,Basosquamous carcinoma in situ (C44._)
8094/3,Basosquamous carcinoma (C44._)
8095/3,Metatypical carcinoma (C44._)
8096/0,Intraepidermal epithelioma of Jadassohn (C44._)
8097/3,"Basal cell carcinoma, nodular (C44._)"
8044/3,"Small cell carcinoma, intermediate cell"
8100/0,Trichoepithelioma (C44._)
8101/0,Trichofolliculoma (C44._)
8102/0,Trichilemmoma (C44._)
8102/3,Trichilemmocarcinoma (C44._)
8103/0,Pilar tumor (C44._)
8103/3,"Pilar tumor, malignant (C44._)"
8120/0,"Transitional cell papilloma, benign"
8120/1,"Urothelial papilloma, NOS (C65.9, C66.9, C67._)"
8120/2,"Transitional cell carcinoma in situ (C65.9, C66.9, C67._)"
8120/3,"Transitional cell carcinoma, NOS (C65.9, C66.9, C67._)"
8121/0,"Schneiderian papilloma, NOS (C30.0, C31._)"
8121/1,"Transitional cell papilloma, inverted, NOS (C30.0, C31._)"
8121/2,"Transitional cell carcinoma in situ, inverted, NOS (C30.0, C31._)"
8121/3,"Schneiderian carcinoma (C30.0, C31._)"
8123/2,"Basaloid carcinoma, in situ (C21.1)"
8124/2,Cloacogenic carcinoma in situ (C21.2)
8124/3,Cloacogenic carcinoma (C21.2)
8130/2,"Papillary transitional cell carcinoma, non-invasive (C65.9, C66.9, C67._)"
8140/2,"Adenocarcinoma in situ, NOS"
8140/3,"Adenocarcinoma, NOS"
8140/6,"Adenocarcinoma, metastatic, NOS"
8141/2,Scirrhous adenocarcinoma in situ
8141/3,Scirrhous adenocarcinoma
8142/3,Linitis plastica (C16._)
8143/2,Superficial spreading adenocarcinoma in situ
8143/3,Superficial spreading adenocarcinoma
8144/3,"Adenocarcinoma, intestinal type (C16._)"
8145/2,"Carcinoma in situ, diffuse type (C16._)"
8145/3,"Carcinoma, diffuse type (C16._)"
8146/0,Monomorphic adenoma
8146/2,"Monomorphic adenoma, in situ"
8146/3,Monomorphic adenocarcinoma
8147/0,"Basal cell adenoma (C07._, C08._)"
8147/3,"Basal cell adenocarcinoma (C07._, C08._)"
8149/0,Canalicular adenoma
8160/0,"Bile duct adenoma (C22.1, C24.0)"
8160/2,"Bile duct adenocarcinoma in situ (C22.1, C24.0)"
8160/3,"Cholangiocarcinoma (C22.1, C24.0)"
8170/0,Liver cell adenoma (C22.0)
8170/3,"Hepatocellular carcinoma, NOS (C22.0)"
8171/3,"Hepatocellular carcinoma, fibrolamellar (C22.0)"
8172/3,"Hepatocellular carcinoma, scirrhous (C22.0)"
8173/3,"Hepatocellular carcinoma, spindle cell variant (C22.0)"
8174/3,"Hepatocellular carcinoma, clear cell type (C22.0)"
8175/3,"Hepatocellular carcinoma, pleomorphic type (C22.0)"
8180/3,Combined hepatocellular carcinoma and cholangiocarcinoma (C22.0)
8190/0,Trabecular adenoma
8190/3,Trabecular adenocarcinoma
8191/0,Embryonal adenoma
8200/0,Eccrine dermal cylindroma (C44._)
8200/2,Adenoid cystic carcinoma in situ
8200/3,Adenoid cystic carcinoma
8201/2,Cribriform carcinoma in situ (C50._)
8202/0,Microcystic adenoma (C25._)
8204/0,Lactating adenoma (C50._)
8210/0,"Adenomatous polyp, NOS"
8210/2,Adenocarcinoma in situ in adenomatous polyp
8210/3,Adenocarcinoma in adenomatous polyp
8211/0,"Tubular adenoma, NOS"
8211/3,Tubular adenocarcinoma
8212/0,Flat adenoma
8215/3,Adenocarcinoma of anal glands (C21.1)
8220/0,Adenomatous polyposis coli (C18._)
8220/2,Adenocarcinoma in situ in adenomatous polyposis coli (C18._)
8100/3,Trichoblastic carcinoma (C44._) [2022+]
8211/2,"Tubular adenoma, high grade [2022+; NOT REPORTABLE; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABILITY.]"
8220/3,Adenocarcinoma in adenomatous polyposis coli (C18._)
8221/0,Multiple adenomatous polyps
8221/2,Adenocarcinoma in situ in multiple adenomatous polyposis coli
8123/3,Basaloid carcinoma
8230/3,"Solid carcinoma, NOS"
8231/3,Carcinoma simplex
8241/3,Enterochromaffin cell carcinoid
8242/1,"Enterochromaffin-like cell carcinoid, NOS"
8242/3,"Enterochromaffin-like cell tumor, malignant"
8244/3,Mixed adenoneuroendocrine carcinoma
8245/1,Tubular carcinoid
8245/3,Adenocarcinoid tumor
8246/3,"Neuroendocrine carcinoma, NOS"
8247/3,Merkel cell carcinoma (C44._)
8248/1,Apudoma
8248/3,"Apudoma, malignant"
8250/1,Pulmonary adenomatosis (C34._)
8251/0,Alveolar adenoma (C34._)
8251/3,Alveolar adenocarcinoma (C34._)
8255/2,"Adenocarcinoma with mixed subtypes, in situ"
8255/3,Adenocarcinoma with mixed subtypes
8260/0,"Papillary adenoma, NOS"
8260/2,"Papillary adenocarcinoma in situ, NOS"
8260/3,"Papillary adenocarcinoma, NOS"
8261/0,"Villous adenoma, NOS"
8261/2,Adenocarcinoma in situ in villous adenoma
8261/3,Adenocarcinoma in villous adenoma
8262/2,Villous adenocarcinoma in situ
8262/3,Villous adenocarcinoma
8263/0,"Tubulovillous adenoma, NOS"
8263/2,Adenocarcinoma in situ in tubulovillous adenoma
8263/3,Adenocarcinoma in tubulovillous adenoma
8264/0,"Papillomatosis, glandular (C22.1, C24.0)"
8270/0,Chromophobe adenoma (C75.1)
8270/1,"Chromophobe adenoma, borderline (C75.1)"
8270/3,Chromophobe carcinoma (C75.1)
8271/0,Prolactinoma (C75.1)
8272/0,"Pituitary adenoma, NOS (C75.1)"
8272/1,"Pituitary, borderline malignancy (C75.1)"
8272/3,"Pituitary carcinoma, NOS (C75.1)"
8280/0,Acidophil adenoma (C75.1)
8280/3,Acidophil carcinoma (C75.1)
8281/0,Mixed acidophil-basophil adenoma (C75.1)
8281/3,Mixed acidophil-basophil carcinoma (C75.1)
8300/0,Basophil adenoma (C75.1)
8300/3,Basophil carcinoma (C75.1)
8310/0,Clear cell adenoma
8310/2,Clear cell adenocarcinoma in situ
8310/3,"Clear cell adenocarcinoma, NOS"
8311/1,Hypernephroid tumor [obs]
8312/2,Renal cell carcinoma in situ (C64.9)
8313/0,Clear cell adenofibroma (C56.9)
8313/3,Clear cell adenocarcinofibroma (C56.9)
8314/3,Lipid-rich carcinoma (C50._)
8315/3,Glycogen-rich carcinoma (C50._)
8316/2,Cyst-associated renal cell carcinoma in situ (C64.9)
8316/3,Cyst-associated renal cell carcinoma (C64.9)
8317/3,"Renal cell carcinoma, chromophobe type (C64.9)"
8318/3,"Renal cell carcinoma, sarcomatoid (C64.9)"
8319/3,Collecting duct carcinoma (C64.9)
8320/3,Granular cell carcinoma
8321/0,Chief cell adenoma (C75.0)
8322/0,Water-clear cell adenoma (C75.0)
8322/3,Water-clear cell adenocarcinoma (C75.0)
8323/0,Mixed cell adenoma
8323/2,Mixed cell adenocarcinoma in situ
8323/3,Mixed cell adenocarcinoma
8324/0,Lipoadenoma
8325/3,Metanephric adenocarcinoma (C64._)
8330/1,Atypical follicular adenoma (C73.9)
8330/2,Follicular adenocarcinoma in situ (C73.9)
8333/0,"Microfollicular adenoma, NOS (C73.9)"
8243/3,Goblet cell adenocarcinoma [2022+]
8334/0,Macrofollicular adenoma (C73.9)
8335/3,"Follicular carcinoma, minimally invasive (C73.9)"
8340/2,"Papillary carcinoma follicular variant, in situ follicular variant (C73.9)"
8340/3,"Papillary carcinoma, follicular variant (C73.9)"
8341/2,Papillary microcarcinoma in situ (C73.9)
8341/3,Papillary microcarcinoma (C73.9)
8342/2,"Papillary carcinoma, encapsulated, in situ (C73.9)"
8343/3,"Papillary carcinoma, encapsulated (C73.9)"
8344/3,"Papillary carcinoma, columnar cell (C73.9)"
8010/6,"Carcinoma, metastatic, NOS"
8346/3,Mixed medullary-follicular carcinoma (C73.9)
8347/3,Mixed medullary-papillary carcinoma (C73.9)
8350/3,Nonencapsulated sclerosing carcinoma (C73.9)
8360/1,Multiple endocrine adenomas (C75.8)
8370/0,"Adrenal cortical adenoma, NOS (C74.0)"
8370/3,Adrenal cortical carcinoma (C74.0)
8371/0,"Adrenal cortical adenoma, compact cell (C74.0)"
8372/0,"Adrenal cortical adenoma, pigmented (C74.0)"
8373/0,"Adrenal cortical adenoma, clear cell (C74.0)"
8374/0,"Adrenal cortical adenoma, glomerulosa cell (C74.0)"
8375/0,"Adrenal cortical adenoma, mixed cell (C74.0)"
8380/0,"Endometrioid adenoma, NOS (C56.9 [F], C61.9 [M])"
8380/1,"Endometrioid adenoma, borderline malignancy (C56.9 [F], C61.9 [M])"
8381/0,"Endometrioid adenofibroma, NOS (C56.9 [F], C61.9 [M])"
8381/1,"Endometrioid adenofibroma, borderline malignancy (C56.9 [F], C61.9 [M])"
8381/3,"Endometrioid adenofibroma, malignant (C56.9 [F], C61.9 [M])"
8382/3,"Endometrioid adenocarcinoma, secretory variant (C56.9 [F], C61.9 [M])"
8383/3,"Endometrioid adenocarcinoma, ciliated cell variant (C56.9 [F], C61.9 [M])"
8384/2,"Adenocarcinoma, endocervical type, in situ (C53._)"
8384/3,"Adenocarcinoma, endocervical type (C53._)"
8390/0,Skin appendage adenoma (C44._)
8390/2,Skin appendage carcinoma in situ (C44._)
8391/0,Follicular fibroma (C44._)
8392/0,Syringofibroadenoma (C44._)
8400/0,Sweat gland adenoma (C44._)
8400/1,"Sweat gland tumor, NOS (C44._)"
8400/2,Sweat gland adenocarcinoma in situ (C44._)
8400/3,Sweat gland adenocarcinoma (C44._)
8401/0,Apocrine adenoma (C44._)
8401/2,Apocrine adenocarcinoma in situ (C44._)
8401/3,Apocrine adenocarcinoma (C44._)
8402/0,Nodular hidradenoma (C44._)
8402/2,"Nodular hidradenoma, in situ (C44._)"
8403/0,Eccrine spiradenoma (C44._)
8403/3,Malignant eccrine spiradenoma (C44._)
8404/0,Hidrocystoma (C44._)
8405/0,Papillary hidradenoma (C44._)
8406/0,Papillary syringadenoma (C44._)
8407/0,"Syringoma, NOS (C44._)"
8408/0,Eccrine papillary adenoma (C44._)
8409/0,Eccrine poroma (C44._)
8410/0,Sebaceous adenoma (C44._)
8410/2,Sebaceous adenocarcinoma in situ (C44._)
8413/3,Eccrine adenocarcinoma (C44._)
8420/0,Ceruminous adenoma (C44.2)
8420/3,Ceruminous adenocarcinoma (C44.2)
8430/1,Mucoepidermoid tumor [OBS]
8430/2,Mucoepidermoid carcinoma in situ
8430/3,Mucoepidermoid carcinoma
8440/0,"Cystadenoma, NOS"
8440/2,"Cystadenocarcinoma, in situ"
8440/3,"Cystadenocarcinoma, NOS"
8441/0,"Serous cystadenoma, NOS (C56.9)"
8442/1,"Serous cystadenoma, borderline malignancy (C56.9)"
8443/0,Clear cell cystadenoma (C56.9)
8443/3,Clear cell cystadenocarcinoma (C56.9)
8444/3,"Clear cell cystic tumor, malignant (C56.9)"
8450/0,"Papillary cystadenoma, NOS (C56.9)"
8450/2,"Papillary cystadenocarcinoma in situ, NOS (C56.9)"
8450/3,"Papillary cystadenocarcinoma, NOS (C56.9)"
8451/1,"Papillary cystadenoma, borderline malignancy (C56.9)"
8380/2,Endometrioid intraepithelial neoplasia (C54._) [2018+; REPORTABLE 2021+]
8406/3,Syringocystadenocarcinoma papilliferum [2022+]
8409/2,Porocarcinoma in situ [2022+]
8453/0,Intraductal papillary-mucinous adenoma (C25._)
8453/2,"Intraductal papillary-mucinous carcinoma, non-invasive (C25._)"
8453/3,"Intraductal papillary-mucinous carcinoma, invasive (C25._)"
8454/0,Cystic tumor of atrio-ventricular node (C38.0)
8460/0,"Papillary serous cystadenoma, NOS (C56.9)"
8461/0,Serous surface papilloma (C56.9)
8461/2,"Serous surface papilloma, in situ (C56.9)"
8463/1,Serous surface papillary tumor of borderline malignancy (C56.9)
8463/3,Serous surface papillary carcinoma (C56.9)
8470/3,"Mucinous cystadenocarcinoma, NOS (C56.9)"
8471/0,"Papillary mucinous cystadenoma, NOS (C56.9)"
8472/1,Mucinous cystic tumor of borderline malignancy (C56.9)
8472/3,Mucinous cystadenocarcinoma (C56.9)
8473/2,"Papillary mucinous cystadenoma, in situ (C56.9)"
8473/3,Papillary pseudomucinous cystadenocarcinoma (C56.9)
8480/0,Mucinous adenoma
8480/6,Pseudomyxoma peritonei (C48.2)
8481/2,Mucin-producing adenocarcinoma in situ
8481/3,Mucin-producing adenocarcinoma
8490/3,Signet ring cell carcinoma
8490/6,Metastatic signet ring cell carcinoma (C56.9)
8501/2,"Comedocarcinoma, noninfiltrating (C50._)"
8501/3,"Comedocarcinoma, NOS (C50._)"
8502/2,"Secretory carcinoma of breast, in situ (C50._)"
8502/3,Secretory carcinoma of breast (C50._)
8503/0,Intraductal papilloma (C50._)
8503/3,Intraductal papillary adenocarcinoma with invasion (C50._)
8504/0,Intracystic papillary adenoma
8505/0,"Intraductal papillomatosis, NOS"
8507/2,Intraductal micropapillary carcinoma (C50._)
8508/2,"Cystic hypersecretory carcinoma, in situ (C50._)"
8512/3,Medullary carcinoma with lymphoid stroma (C50._)
8513/3,Atypical medullary carcinoma (C50._)
8514/3,"Duct carcinoma, desmoplastic type (C50._)"
8520/3,"Lobular carcinoma, NOS (C50._)"
8521/2,Ductular carcinoma in situ (C50._)
8522/3,Infiltrating duct and lobular carcinoma (C50._)
8523/2,Intraductal with other types of carcinoma in situ (C50._)
8524/3,Infiltrating lobular mixed with other types of carcinoma (C50._)
8525/3,Polymorphous low grade adenocarcinoma
8530/3,Inflammatory carcinoma (C50._)
8540/2,"Paget disease, mammary in situ (C50._)"
8540/3,"Paget disease, mammary (C50._)"
8542/2,"Paget disease (in situ), extramammary (except Paget disease of bone) (C50._)"
8542/3,"Paget disease, extramammary (except Paget disease of bone)"
8543/2,Paget disease in situ and intraductal carcinoma (C50._)
8550/0,Acinar cell adenoma
8550/1,Acinar cell tumor [obs]
8550/2,Acinar cell carcinoma in situ
8551/3,Acinar cell cystadenocarcinoma
8560/0,Mixed squamous cell and glandular papilloma
8560/2,Squamous cell carcinoma in situ and glandular papilloma
8560/3,Adenosquamous carcinoma
8561/0,"Adenolymphoma (C07._, C08._)"
8561/3,"Warthin tumor, malignant (C07._, C08._)"
8562/2,Epithelial-myoepithelial carcinoma in situ
8562/3,Epithelial-myoepithelial carcinoma
8570/3,Adenocarcinoma with squamous metaplasia
8521/3,Infiltrating ductular carcinoma (C50._)
8472/2,Papillary mucinous carcinoma in situ
8503/2,"Ductal carcinoma in situ, papillary (C50._)"
8571/3,Adenocarcinoma with cartilaginous and osseous metaplasia
8572/3,Adenocarcinoma with spindle cell metaplasia
8573/2,Adenocarcinoma in situ with apocrine metaplasia
8573/3,Adenocarcinoma with apocrine metaplasia
8574/3,Adenocarcinoma with neuroendocrine differentiation
8575/3,"Metaplastic carcinoma, NOS"
8576/3,Hepatoid adenocarcinoma
8580/0,"Thymoma, benign (C37.9)"
8586/3,"Thymic carcinoma, NOS (C37.9)"
8587/0,Ectopic hamartomatous thymoma (C37.9)
8588/3,Spindle epithelial tumor with thymus-like element (C37.9)
8590/1,"Sex cord-gonadal stromal tumor, NOS (C56.9 [F], C62._[M])"
8482/3,"Mucinous carcinoma, gastric type"
8590/3,"Sex cord-gonadal stromal tumor, malignant, NOS (C56.9 [F], C62._[M])"
8591/1,"Sex cord-gonadal stromal tumor, incompletely differentiated (C56.9 [F], C62._[M])"
8592/1,"Sex cord-gonadal stromal tumor, mixed forms (C56.9 [F], C62._[M])"
8593/1,Stromal tumor with minor sex cord elements (C56.9)
8593/3,"Malignant stromal tumor, with sex cord elements (C56.9)"
8600/0,"Thecoma, NOS (C56.9)"
8600/3,"Thecoma, malignant (C56.9)"
8601/0,"Thecoma, luteinized (C56.9)"
8602/0,Sclerosing stromal tumor (C56.9)
8602/3,"Sclerosing stromal tumor, malignant (C56.9)"
8610/0,"Luteoma, NOS (C56.9)"
8621/1,Granulosa cell-theca cell tumor (C56.9)
8621/3,"Granulosa cell-theca cell tumor, malignant (C56.9)"
8622/1,"Granulosa cell tumor, juvenile (C56.9)"
8622/3,"Juvenile granulosa cell tumor, malignant (C56.9)"
8623/1,Sex cord tumor with annular tubules (C56.9)
8623/3,"Sex cord tumor with annular tubules, malignant (C56.9)"
8630/0,"Androblastoma, benign (C56.9 [F], C62._[M])"
8630/1,"Androblastoma, NOS (C56.9 [F], C62._[M])"
8630/3,"Androblastoma, malignant (C56.9 [F], C62._[M])"
8631/0,"Sertoli-Leydig cell tumor, well differentiated (C56.9 [F], C62._[M])"
8631/1,"Sertoli-Leydig cell tumor of intermediate differentiation (C56.9 [F], C62._[M])"
8631/3,"Sertoli-Leydig cell tumor, poorly differentiated (C56.9 [F], C62._[M])"
8632/1,"Gynandroblastoma (C56.9 [F], C62._[M])"
8632/3,"Gynandroblastoma, malignant (C56.9 [F], C62._[M])"
8633/1,"Sertoli-Leydig cell tumor, retiform (C56.9 [F], C62._[M])"
8634/1,"Sertoli-Leydig cell tumor, intermediate differentiation, with heterologous elements"
8634/3,"Sertoli-Leydig cell tumor, poorly differentiated with heterologous elements (C56.9 [F], C62._[M])"
8640/1,"Sertoli cell tumor, NOS (C56.9 [F], C62._[M])"
8640/3,"Sertoli cell carcinoma (C56.9 [F], C62._[M])"
8641/0,"Sertoli cell tumor with lipid storage (C56.9 [F], C62._[M])"
8642/1,"Large cell calcifying Sertoli cell tumor (C56.9 [F], C62._[M])"
8650/0,"Leydig cell tumor, benign (C56.9 [F], C62._[M])"
8650/1,"Leydig cell tumor, NOS (C56.9 [F], C62._[M])"
8650/3,"Leydig cell tumor, malignant (C56.9 [F], C62._[M])"
8660/0,Hilus cell tumor (C56.9)
8670/0,Lipid cell tumor of ovary (C56.9)
8670/3,"Steroid cell tumor, malignant (C56.9)"
8671/0,Adrenal rest tumor
8683/0,Gangliocytic paraganglioma (C17.0)
8683/3,"Gangliocytic paraganglioma, malignant (C17.0)"
8710/3,Glomangiosarcoma (C49._)
8711/0,"Glomus tumor, NOS"
8711/3,"Glomus tumor, malignant (C49._)"
8712/0,Glomangioma
8712/3,"Glomangioma, malignant (C49._)"
8713/0,Glomangiomyoma
8720/0,"Pigmented nevus, NOS (C44._)"
8720/2,Melanoma in situ (C44._)
8721/2,"Nodular melanoma, in situ (C44._)"
8721/3,Nodular melanoma (C44._)
8722/0,Balloon cell nevus (C44._)
8722/2,"Balloon cell melanoma, in situ (C44._)"
8722/3,Balloon cell melanoma (C44._)
8725/0,Neuronevus (C44._)
8726/0,Magnocellular nevus (C69.4)
8726/3,Malignant melanoma in magnocellular nevus (C69.4)
8727/3,"Dysplastic nevus, malignant (C44._)"
8728/0,Diffuse melanocytosis (C70.9)
8728/1,Meningeal melanocytoma (C70.9)
8730/0,Nonpigmented nevus (C44._)
8730/3,Amelanotic melanoma (C44._)
8740/0,"Junctional nevus, NOS (C44._)"
8740/2,Melanoma in situ in junctional nevus (C44._)
8740/3,Malignant melanoma in junctional nevus (C44._)
8741/2,"Precancerous melanosis, NOS (C44._)"
8741/3,Malignant melanoma in precancerous melanosis (C44._)
8742/2,Lentigo maligna (C44._)
8742/3,Lentigo maligna melanoma (C44._)
8743/2,Superficial spreading melanoma in situ (C44._)
8744/2,"Acral lentiginous melanoma, in situ (C44._)"
8745/2,"Desmoplastic melanoma, in situ (C44._)"
8745/3,"Desmoplastic melanoma, malignant (C44._)"
8746/2,Mucosal lentiginous melanoma in situ (C44._)
8746/3,Mucosal lentiginous melanoma (C44._)
8750/0,Intradermal nevus (C44._)
8760/0,Compound nevus (C44._)
8760/2,Melanoma in situ in compound nevus (C44._)
8761/0,Small congenital nevus (C44._)
8761/1,"Giant pigmented nevus, NOS (C44._)"
8761/2,Melanoma in situ in giant pigmented nevus (C44._)
8762/1,Proliferative dermal lesion in congenital nevus (C44._)
8770/0,Epithelioid and spindle cell nevus (C44._)
8770/2,Epithelioid and spindle cell melanoma in situ (C44._)
8771/0,Epithelioid cell nevus (C44._)
8771/2,Epithelioid cell melanoma in situ (C44._)
8771/3,Epithelioid cell melanoma (C44._)
8772/0,"Spindle cell nevus, NOS (C44._)"
8772/2,"Spindle cell melanoma in situ, NOS (C44._)"
8772/3,"Spindle cell melanoma, NOS (C44._)"
8773/3,"Spindle cell melanoma, type A (C69._)"
8774/3,"Spindle cell melanoma, type B (C69._)"
8780/0,"Blue nevus, NOS (C44._)"
8780/3,"Blue nevus, malignant (C44._)"
8790/0,Cellular blue nevus (C44._)
8790/3,"Cellular blue nevus, malignant (C44._)"
8800/0,"Soft tissue tumor, benign (C49._)"
8800/9,"Sarcomatosis, NOS (C47._, C49._)"
8801/3,Spindle cell sarcoma (C49._)
8803/3,Small cell sarcoma (C49._)
8804/3,Epithelioid sarcoma (C49._)
8805/3,Undifferentiated sarcoma (C49._)
8806/3,Desmoplastic small round cell tumor (C49._)
8810/0,"Fibroma, NOS (C49._)"
8810/1,Cellular fibroma (C56.9)
8810/3,"Fibrosarcoma, NOS (C49._)"
8811/0,Fibromyxoma (C49._)
8812/0,"Periosteal fibroma (C40._, C41._)"
8812/3,"Periosteal fibrosarcoma (C40._,C41._)"
8813/0,Fascial fibroma (C49._)
8813/3,Fascial fibrosarcoma (C49._)
8814/3,Infantile fibrosarcoma (C49._)
8815/0,Solitary fibrous tumor (C49._)
8815/3,"Solitary fibrous tumor, malignant (C49._)"
8820/0,Elastofibroma (C49._)
8822/1,Abdominal fibromatosis (C49._)
8823/3,Desmoplastic fibrosarcoma (C49._)
8824/0,Myofibroma (C49._)
8824/1,Myofibromatosis (C49._)
8824/3,"Myofibroma, malignant (C49._)"
8825/0,Myofibroblastoma (C49._)
8825/1,"Myofibroblastic tumor, NOS (C49._)"
8826/0,Angiomyofibroblastoma (C49._)
8827/1,"Myofibroblastic tumor, peribronchial (C34._)"
8830/0,Benign fibrous histiocytoma (C49._)
8830/1,Atypical fibrous histiocytoma (C49._)
8830/3,Malignant fibrous histiocytoma (C49._)
8831/0,"Histiocytoma, NOS (C49._)"
8831/3,"Histiocytoma, NOS, malignant (C49._)"
8832/0,"Dermatofibroma, NOS (C44._)"
8834/1,Giant cell fibroblastoma
8835/1,Plexiform fibrohistiocytic tumor
8835/3,Malignant plexiform fibrohistiocytic tumor
8836/1,Angiomatoid fibrous histiocytoma
8836/3,Malignant angiomatoid fibrous histiocytoma
8840/0,"Myxoma, NOS (C49._)"
8840/3,Myxosarcoma (C49._)
8841/3,"Angiomyxoma, malignant (C49._)"
8821/1,Aggressive fibromatosis
8821/3,"Aggressive fibromatosis, malignant (C49._) [pre-2023]"
8842/0,Ossifying fibromyxoid tumor
8850/0,"Lipoma, NOS"
8850/1,Atypical lipoma
8850/3,"Liposarcoma, NOS (C49._)"
8851/0,Fibrolipoma
8851/3,"Liposarcoma, well differentiated (C49._)"
8852/0,Fibromyxolipoma
8852/3,Myxoid liposarcoma (C49._)
8853/3,Round cell liposarcoma (C49._)
8854/0,Pleomorphic lipoma
8854/3,Pleomorphic liposarcoma (C49._)
8855/3,Mixed liposarcoma (C49._)
8856/0,Intramuscular lipoma
8857/0,Spindle cell lipoma
8857/3,Fibroblastic liposarcoma (C49._)
8858/3,Dedifferentiated liposarcoma (C49._)
8860/0,Angiomyolipoma
8860/3,Angiomyoliposarcoma (C49._)
8861/0,"Angiolipoma, NOS"
8862/0,Chondroid lipoma
8870/0,Myelolipoma
8880/0,Hibernoma
8881/0,Lipoblastomatosis
8890/0,"Leiomyoma, NOS (C54._, C55.9)"
8890/3,"Leiomyosarcoma, NOS (C54._, C55.9)"
8891/0,Epithelioid leiomyoma (C49._)
8891/3,Epithelioid leiomyosarcoma (C49._)
8892/0,Cellular leiomyoma (C49._)
8893/0,Bizarre leiomyoma (C49._)
8893/3,"Bizarre leiomyoma, malignant (C49._)"
8894/0,Angiomyoma (C49._)
8894/3,Angiomyosarcoma (C49._)
8895/0,Myoma (C49._)
8895/3,Myosarcoma (C49._)
8896/3,Myxoid leiomyosarcoma (C49._)
8897/1,Smooth muscle tumor of uncertain malignant potential (C49._)
8897/3,Malignant tumor of smooth muscle (C49._)
8898/1,Metastasizing leiomyoma (C49._)
8900/0,"Rhabdomyoma, NOS (C49._)"
8900/3,"Rhabdomyosarcoma, NOS (C49._)"
8901/3,"Pleomorphic rhabdomyosarcoma, adult type (C49._)"
8902/3,Mixed type rhabdomyosarcoma (C49._)
8903/0,Fetal rhabdomyoma (C49._)
8904/0,Adult rhabdomyoma (C49._)
8910/3,"Embryonal rhabdomyosarcoma, NOS (C49._)"
8912/3,Spindle cell rhabdomyosarcoma (C49._)
8920/3,Alveolar rhabdomyosarcoma (C49._)
8930/0,Endometrial stromal nodule (C54.1)
8930/3,"Endometrial stromal sarcoma, NOS (C54.1)"
8932/0,Adenomyoma
8933/3,Adenosarcoma
8934/3,Carcinofibroma
8935/0,"Stromal tumor, benign (C54.1)"
8935/1,"Stromal tumor, NOS (C54.1)"
8935/3,"Stromal sarcoma, NOS (C54.1)"
8936/0,"Gastrointestinal stromal tumor, benign (C26.9)"
8936/2,"Gastrointestinal stromal tumor, NOS, in situ (C26.9)"
8940/0,"Pleomorphic adenoma (C07._, C08._)"
8941/2,"Carcinoma in situ in pleomorphic adenoma (C07._, C08._)"
8941/3,"Carcinoma in pleomorphic adenoma (C07._, C08._)"
8950/3,Mullerian mixed tumor (C54._)
8960/1,Mesoblastic nephroma (C64._)
8970/3,Hepatoblastoma (C22.0)
8972/3,Pulmonary blastoma (C34._)
8973/3,Pleuropulmonary blastoma (C34._)
8974/1,Sialoblastoma
8980/3,"Carcinosarcoma, NOS"
8981/3,"Carcinosarcoma, embryonal"
8982/0,Myoepithelioma
8983/0,Adenomyoepithelioma (C50._)
8991/3,Embryonal sarcoma (C49._)
9000/0,"Brenner tumor, NOS (C56.9)"
9000/1,"Brenner tumor, borderline malignancy (C56.9)"
9000/3,"Brenner tumor, malignant (C56.9)"
9010/0,"Fibroadenoma, NOS (C50._)"
9011/0,Intracanalicular fibroadenoma (C50._)
9012/0,Pericanalicular fibroadenoma (C50._)
9013/0,"Adenofibroma, NOS (C56.9)"
9013/3,"Adenofibroma, malignant (C56.9)"
9014/0,"Serous adenofibroma, NOS (C56.9)"
9014/1,Serous adenofibroma of borderline malignancy (C56.9)
9014/2,"Serous adenocarcinofibroma, in situ (C56.9)"
9014/3,Serous adenocarcinofibroma (C56.9)
9015/0,"Mucinous adenofibroma, NOS (C56.9)"
9015/1,Mucinous adenofibroma of borderline malignancy (C56.9)
9015/3,Mucinous adenocarcinofibroma (C56.9)
9016/0,Giant fibroadenoma (C50._)
9020/0,"Phyllodes tumor, benign (C50._)"
9020/1,"Phyllodes tumor, borderline (C50._)"
9020/3,"Phyllodes tumor, malignant (C50._)"
9030/0,Juvenile fibroadenoma (C50._)
9040/0,"Synovioma, benign (C49._)"
9040/3,"Synovial sarcoma, NOS (C49._)"
9041/3,"Synovial sarcoma, spindle cell (C49._)"
9042/3,"Synovial sarcoma, epithelioid cell (C49._)"
9043/3,"Synovial sarcoma, biphasic (C49._)"
9050/0,"Mesothelioma, benign"
9050/3,"Mesothelioma, malignant"
9051/0,"Fibrous mesothelioma, benign"
9051/3,"Fibrous mesothelioma, malignant"
9052/0,"Epithelioid mesothelioma, benign"
9052/3,"Epithelioid mesothelioma, malignant"
9053/3,"Mesothelioma, biphasic, malignant"
9054/0,"Adenomatoid tumor, NOS"
9054/3,"Adenomatoid tumor, malignant"
9055/0,"Multicystic mesothelioma, benign (C48._)"
9055/1,"Cystic mesothelioma, NOS (C48._)"
9055/3,"Multicystic mesothelioma, malignant (C48._)"
9060/2,"Dysgerminoma, in situ (C56.9 [F], C62._[M])"
9060/3,"Dysgerminoma (C56.9 [F], C62._[M])"
9061/3,"Seminoma, NOS (C62._)"
9062/3,"Seminoma, anaplastic (C62._)"
9063/2,"Spermatocytic seminoma, in situ (C62._)"
9063/3,Spermatocytic seminoma (C62._)
9064/2,Intratubular malignant germ cells (C62._)
9064/3,Germinoma (C62._)
9065/3,"Germ cell tumor, nonseminomatous (C62._)"
9070/3,"Embryonal carcinoma, NOS"
9071/3,"Yolk sac tumor (C56.9 [F], C62._[M])"
9072/3,Polyembryoma
9073/1,"Gonadoblastoma (C56.9 [F], C62._[M])"
9080/0,"Teratoma, benign"
9080/1,"Teratoma, NOS"
9081/2,"Teratocarcinoma, in situ (C22.0)"
9081/3,Teratocarcinoma (C22.0)
9082/3,"Malignant teratoma, undifferentiated"
9083/3,"Malignant teratoma, intermediate"
9084/0,"Dermoid cyst, NOS"
9084/2,"Dermoid cyst, in situ, NOS"
9084/3,Teratoma with malignant transformation
9085/2,"Mixed germ cell tumor, in situ"
9085/3,Mixed germ cell tumor
9090/0,"Struma ovarii, NOS (C56.9)"
9090/3,"Struma ovarii, malignant (C56.9)"
9091/1,Strumal carcinoid (C56.9)
9091/3,"Strumal carcinoid, malignant (C56.9)"
9100/0,"Hydatidiform mole, NOS (C58.9)"
9100/1,Invasive hydatidiform mole (C58.9)
9100/3,"Choriocarcinoma, NOS (C58.9)"
9101/3,Choriocarcinoma combined with other germ cell elements
9102/3,"Malignant teratoma, trophoblastic (C62._)"
9103/0,Partial hydatidiform mole (C58.9)
9103/3,"Partial hydatidiform mole, malignant (C58.9)"
9104/1,Placental site trophoblastic tumor (C58.9)
9105/3,"Trophoblastic tumor, epithelioid"
9110/0,"Mesonephroma, benign"
9110/1,"Mesonephric tumor, NOS"
9120/0,"Hemangioma, NOS"
9120/3,Hemangiosarcoma (C49._)
9121/0,Cavernous hemangioma
9121/1,"Cavernous hemangioma, borderline"
9122/0,Venous hemangioma
9123/0,Racemose hemangioma
9124/3,Kupffer cell sarcoma (C22.0)
9125/0,Epithelioid hemangioma
9125/3,"Epithelioid hemangioma, malignant (C49._)"
9130/0,"Hemangioendothelioma, benign"
9130/1,"Hemangioendothelioma, NOS"
9130/3,"Hemangioendothelioma, malignant (C49._)"
9131/0,Capillary hemangioma
9132/0,Intramuscular hemangioma
9133/1,"Epithelioid hemangioendothelioma, NOS"
9135/1,Endovascular papillary angioendothelioma
9136/1,Spindle cell hemangioendothelioma
9140/3,Kaposi Sarcoma
9141/0,Angiokeratoma
9142/0,Verrucous keratotic hemangioma
9150/0,"Hemangiopericytoma, benign"
9150/1,"Hemangiopericytoma, NOS (C49._)"
9150/3,"Hemangiopericytoma, malignant (C49._)"
9160/0,"Angiofibroma, NOS"
9161/0,Acquired tufted hemangioma
9161/1,Hemangioblastoma (C49._)
9161/3,"Hemangioblastoma, malignant (C49._)"
9170/0,"Lymphangioma, NOS"
9170/3,Lymphangiosarcoma (C49._)
9171/0,Capillary lymphangioma
9172/0,Cavernous lymphangioma
9173/0,Cystic lymphangioma
9174/0,Lymphangiomyoma
9175/0,Hemolymphangioma
9180/0,"Osteoma, NOS (C40._, C41._)"
9180/3,"Osteosarcoma, NOS (C40._, C41._)"
9181/3,"Chondroblastic osteosarcoma (C40._, C41._)"
9110/3,"Adenocarcinoma, HPV-independent, mesonephric type [2021+]"
9061/2,Intratubular seminoma (C62._) [2024+]
9070/2,Intratubular embryonal carcinoma [2024+]
9182/3,"Fibroblastic osteosarcoma (C40._, C41._)"
9183/3,"Telangiectatic osteosarcoma (C40._, C41._)"
9184/3,"Osteosarcoma in Paget disease of bone (C40._, C41._)"
9185/3,"Small cell osteosarcoma (C40._, C41._)"
9186/3,"Central osteosarcoma (C40._, C41._)"
9187/3,"Intraosseous well differentiated osteosarcoma (C40._, C41._)"
9192/3,"Parosteal osteosarcoma (C40._, C41._)"
9193/3,"Periosteal osteosarcoma (C40._, C41._)"
9194/3,"High grade surface osteosarcoma (C40._, C41._)"
9195/3,"Intracortical osteosarcoma (C40._, C41._)"
9210/0,"Osteochondroma (C40._, C41._)"
9210/1,"Osteochondromatosis, NOS (C40._, C41._)"
9220/1,"Chondromatosis, NOS (C40._, C41._)"
9220/3,"Chondrosarcoma, NOS (C40._, C41._)"
9221/0,"Juxtacortical chondroma (C40._, C41._)"
9221/3,"Juxtacortical chondrosarcoma (C40._, C41._)"
9230/0,"Chondroblastoma, NOS (C40._, C41._)"
9230/3,"Chondroblastoma, malignant (C40._, C41._)"
9231/3,"Myxoid chondrosarcoma (C40._, C41._)"
9240/3,Mesenchymal chondrosarcoma (C49._)
9241/0,"Chondromyxoid fibroma (C40._, C41._)"
9242/3,"Clear cell chondrosarcoma (C40._, C41._)"
9243/3,"Dedifferentiated chondrosarcoma (C40._, C41._)"
9250/1,"Giant cell tumor of bone, NOS (C40._, C41._)"
9250/3,"Giant cell tumor of bone, malignant (C40._, C41._)"
9251/1,"Giant cell tumor of soft parts, NOS (C49._)"
9251/3,Malignant giant cell tumor of soft parts (C49._)
9252/0,Tenosynovial giant cell tumor (C49._)
9252/3,Malignant tenosynovial giant cell tumor (C49._)
9261/3,"Adamantinoma of long bones (C40._, C41._)"
9262/0,"Ossifying fibroma (C40._, C41._)"
9270/0,"Odontogenic tumor, benign (C41._)"
9270/1,"Odontogenic tumor, NOS (C41._)"
9270/3,"Odontogenic tumor, malignant (C41._)"
9271/0,Ameloblastic fibrodentinoma (C41._)
9272/0,"Cementoma, NOS (C41._)"
9273/0,"Cementoblastoma, benign (C41._)"
9274/0,Cementifying fibroma (C41._)
9275/0,Gigantiform cementoma (C41._)
9280/0,"Odontoma, NOS (C41._)"
9281/0,Compound odontoma (C41._)
9282/0,Complex odontoma (C41._)
9282/3,"Complex odontoma, malignant (C41._)"
9290/0,Ameloblastic fibro-odontoma (C41._)
9290/3,Ameloblastic odontosarcoma (C41._)
9300/0,Adenomatoid odontogenic tumor (C41._)
9301/0,Calcifying odontogenic cyst (C41._)
9302/0,Odontogenic ghost cell tumor (C41._)
9310/0,"Ameloblastoma, NOS (C41._)"
9311/0,Odontoameloblastoma (C41._)
9312/0,Squamous odontogenic tumor (C41._)
9312/3,"Squamous odontogenic tumor, malignant (C41._)"
9320/0,Odontogenic myxoma (C41._)
9321/0,Central odontogenic fibroma (C41._)
9322/0,Peripheral odontogenic fibroma (C41._)
9330/0,Ameloblastic fibroma (C41._)
9330/3,Ameloblastic fibrosarcoma (C41._)
9340/0,Calcifying epithelial odontogenic tumor (C41._)
9341/1,Clear cell odontogenic tumor (C41._)
9342/3,Odontogenic carcinosarcoma (C41._)
9350/0,"Craniopharyngioma, benign (C75.2)"
9350/1,Craniopharyngioma (C75.2)
9350/3,"Craniopharyngioma, malignant (C75.2)"
9351/0,"Craniopharyngioma, adamantinomatous, benign (C75.2)"
9352/0,"Papillary craniopharyngioma, benign (C75.2)"
9360/0,"Pinealoma, benign (C75.3)"
9360/1,"Pinealoma, NOS (C75.3)"
9360/3,"Pinealoma, malignant (C75.3)"
9361/1,Pineocytoma (C75.3)
9362/3,Pineoblastoma (C75.3)
9363/3,"Melanotic neuroectodermal tumor, malignant (C40._, C41._)"
9365/3,Askin tumor
9370/3,"Chordoma, NOS"
9371/3,Chondroid chordoma
9372/3,Dedifferentiated chordoma
9373/0,Parachordoma
9380/0,"Glioma, benign (C71._)"
9380/3,"Glioma, malignant (C71._)"
9381/0,"Gliomatosis cerebri, benign (C71._)"
9381/3,Gliomatosis cerebri (C71._)
9382/3,Mixed glioma (C71._)
9383/1,Subependymoma (C71._)
9383/3,"Subependymoma, malignant (C71._)"
9384/3,"Supependymal giant cell astrocytoma, malignant (C71._)"
9390/0,"Choroid plexus papilloma, NOS (C71.5)"
9390/1,Atypical choroid plexus papilloma (C71.5)
9200/0,"Osteoblastoma, NOS (C40._, C41._) [PRE-2022 ONLY. FOR 2022+ USE CODE 9200/1; NOT REPORTABLE]"
9200/1,"Osteoblastoma, NOS (C40._, C41._) [2022+. FOR PRE-2022, USE CODE 9200/0; NOT REPORTABLE]"
9392/3,"Ependymoma, anaplastic (C71._)"
9393/0,"Papillary ependymoma, benign (C71._)"
9394/3,"Myxopapillary ependymoma, malignant (C71._)"
9400/1,"Astrocytoma, borderline malignancy (C71._)"
9400/3,"Astrocytoma, NOS (C71._)"
9401/3,"Astrocytoma, anaplastic (C71._)"
9410/3,Protoplasmic astrocytoma (C71._)
9411/3,Gemistocytic astrocytoma (C71._)
9412/1,Desmoplastic infantile astrocytoma (C71._)
9413/0,Dysembryoplastic neuroepithelial tumor
9413/1,"Dysembryoplastic neuroepithelial tumor, borderline"
9413/3,"Dysembryoplastic neuroepithelial tumor, malignant"
9420/3,Fibrillary astrocytoma (C71._)
9423/3,Polar spongioblastoma (C71._)
9424/3,Pleomorphic xanthoastrocytoma (C71._)
9430/3,Astroblastoma (C71._)
9440/3,"Glioblastoma, NOS (C71._)"
9441/3,Giant cell glioblastoma (C71._)
9442/1,Gliofibroma (C71._)
9442/3,Gliosarcoma (C71._)
9444/1,Chordoid glioma (C71._)
9450/0,"Oligodendroglioma, benign (C71._)"
9450/3,"Oligodendroglioma, NOS (C71._)"
9451/3,"Oligodendroglioma, anaplastic (C71._)"
9470/3,"Medulloblastoma, NOS (C71.6)"
9471/3,Desmoplastic nodular medulloblastoma (C71.6)
9472/3,Medullomyoblastoma (C71.6)
9474/3,Large cell medulloblastoma (C71.6)
9500/2,"Neuroblastoma, in situ"
9501/0,"Medulloepithelioma, benign (C69.4)"
9501/3,"Medulloepithelioma, NOS (C69.4)"
9502/0,"Teratoid medulloepithelioma, benign (C69.4)"
9503/3,"Neuroepithelioma, NOS"
9504/3,Spongioneuroblastoma
9505/1,"Ganglioglioma, NOS"
9505/3,"Ganglioglioma, anaplastic"
9506/0,"Central neurocytoma, benign (C71.6)"
9506/1,Central neurocytoma
9506/3,"Neurocytoma, malignant"
9507/0,Pacinian tumor
9510/0,Retinocytoma (C69.2)
9510/3,"Retinoblastoma, NOS (C69.2)"
9511/3,"Retinoblastoma, differentiated (C69.2)"
9512/3,"Retinoblastoma, undifferentiated (C69.2)"
9513/3,"Retinoblastoma, diffuse (C69.2)"
9514/1,"Retinoblastoma, spontaneously regressed (C69.2)"
9520/3,Olfactory neurogenic tumor (C30.0)
9521/3,Olfactory neurocytoma (C30.0)
9522/3,Olfactory neuroblastoma (C30.0)
9523/3,Olfactory neuroepithelioma (C30.0)
9530/0,"Meningioma, NOS (C70._)"
9530/1,"Meningiomatosis, NOS (C70._)"
9530/3,"Meningioma, malignant (C70._)"
9531/1,"Meningiothelial meningioma, borderline (C70._)"
9531/3,"Meningiothelial meningioma, malignant (C70._)"
9532/0,Fibrous meningioma (C70._)
9532/3,"Fibrous meningioma, malignant (C70._)"
9533/0,Psammomatous meningioma (C70._)
9533/3,"Psammomatous meningioma, malignant (C70._)"
9534/0,Angiomatous meningioma (C70._)
9534/3,"Angiomatous meningioma, malignant (C70._)"
9535/0,Hemangioblastic meningioma [OBS] (C70._)
9535/3,"Hemangioblastic meningioma, malignant (C70._)"
9537/0,Transitional meningioma (C70._)
9537/3,"Transitional meningioma, malignant (C70._)"
9538/0,"Clear cell meningioma, benign (C70._)"
9538/1,Clear cell meningioma (C70._)
9538/3,Papillary meningioma (C70._)
9539/0,"Atypical meningioma, benign (C70._)"
9539/3,Meningeal sarcomatosis (C70._)
9540/0,"Neurofibroma, NOS"
9540/3,Malignant peripheral nerve sheath tumor
9541/0,Melanotic neurofibroma
9560/0,"Neurilemoma, NOS"
9560/3,"Neurilemoma, malignant [OBS]"
9561/3,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation
9562/0,Neurothekeoma
9562/3,"Neurothekeoma, malignant"
9570/0,"Neuroma, NOS"
9571/1,"Perineurioma, borderline malignant"
9571/3,"Perineurioma, malignant"
9580/0,"Granular cell tumor, NOS (C49._)"
9500/0,"Neuroblastoma, benign"
9500/3,"Neuroblastoma, NOS"
9391/3,Sellar ependymoma (C75.1) [2021+]
9480/3,"Cerebellar sarcoma, NOS (C71.6) [obs]"
9580/3,"Granular cell tumor, malignant (C49._)"
9581/3,Alveolar soft part sarcoma (C49._)
9590/3,"Malignant lymphoma, NOS"
9678/3,Primary effusion lymphoma
9691/3,"Follicular lymphoma, grade 2"
9695/3,"Follicular lymphoma, grade 1"
9698/3,"Follicular lymphoma, grade 3"
9700/3,Mycosis fungoides (C44._)
9705/3,Angioimmunoblastic T-cell lymphoma
9740/3,Mast cell sarcoma
9742/3,Mast cell leukemia (C42.1)
9755/3,Histiocytic sarcoma
9756/3,Langerhans cell sarcoma
9757/3,Interdigitating dendritic cell sarcoma
9758/3,Follicular dendritic cell sarcoma
9762/3,Heavy chain disease
9765/1,Monoclonal gammopathy of undetermined significance
9766/1,Angiocentric immunoproliferative lesion
9769/1,Immunoglobulin deposition disease
9769/3,"Immunoglobulin deposition disease, malignant"
9699/3,"Marginal zone B-cell lymphoma, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9800/3,"Leukemia, NOS (C42.1)"
9820/3,"Lymphoid leukemia, NOS (C42.1)"
9832/3,"Prolymphocytic leukemia, NOS (C42.1)"
9840/3,Acute erythroid leukemia (C42.1)
9860/3,"Myeloid leukemia, NOS (C42.1)"
9861/3,"Acute myeloid leukemia, NOS (C42.1)"
9863/3,"Chronic myeloid leukemia, NOS (C42.1)"
9867/3,Acute myelomonocytic leukemia (C42.1)
9870/3,Acute basophilic leukemia (C42.1)
8921/3,Ectomesenchymoma
9873/3,Acute myeloid leukemia without maturation (C42.1)
9910/3,Acute megakaryoblastic leukemia (C42.1)
9930/3,Myeloid sarcoma
9931/3,Acute panmyelosis with myelofibrosis (C42.1)
9940/3,Hairy cell leukemia (C42.1)
9946/3,Juvenile myelomonocytic leukemia (C42.1)
9948/3,Aggressive NK-cell leukemia (C42.1)
9950/3,Polycythemia vera (C42.1)
9962/3,Essential thrombocythemia (C42.1)
9963/3,Chronic neutrophilic leukemia (C42.1)
9970/3,"Lymphoproliferative disease, malignant, NOS"
8723/3,"Malignant melanoma, regressing (C44._)"
8723/0,Halo nevus (C44._)
8594/1,"Mixed germ cell sex cord-stromal tumor, unclassified (C48.2, C56.9, C57.9)"
8975/1,Calcifying nested epithelial stromal tumor (C22.0)
9137/3,Intimal sarcoma
9302/3,"Ghost cell odontogenic carcinoma (C41.0, C41.1)"
9341/3,"Clear cell odontogenic carcinoma (C41.0, C41.1)"
9741/1,Indolent systemic mastocytosis
8250/3,Lepidic adenocarcinoma (C34._)
8250/2,"Adenocarcinoma in situ, non-mucinous (C34._)"
8254/3,Mixed invasive mucinous and non-mucinous adenocarcinoma (C34._)
8825/3,Myofibroblastic sarcoma
8983/3,Adenomyoepithelioma with carcinoma (C50._)
9133/3,Epithelioid hemangioendothelioma
8148/2,"Glandular intraepithelial neoplasia, grade III"
9490/0,Ganglioneuroma
9490/3,Ganglioneuroblastoma
9491/0,Ganglioneuromatosis
9492/0,Gangliocytoma
8085/3,"Squamous cell carcinoma, HPV-positive (C01.9, C09.9, C10.2, C10.3, C10.8, C10.9, C31.0-C31.3, C31.9)"
8086/3,"Squamous cell carcinoma, HPV-negative (C01.9, C09.9, C10.2, C10.3, C10.8, C10.9, C31.0-C31.3, C31.9)"
8523/3,Infiltrating duct mixed with other types of carcinoma (C50._)
8158/3,"ACTH-producing tumor [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8158/1]"
8273/3,Pituitary blastoma (C75.1) [REPORTABLE 2021+]
8335/1,Follicular tumor of uncertain malignant potential (C73.9)
8349/1,"Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) (C73.9) [2021+ NOT REPORTABLE. FOR 2017-2020, USE CODE 8343/2]"
8681/3,Sympathetic paraganglioma [REPORTABLE 2021+]
8682/3,Parasympathetic paraganglioma [REPORTABLE 2021+]
8742/0,Lentiginous melanocytic nevus (C44._) [2021+]
8832/1,"Dermatofibrosarcoma protuberans, NOS (C44._) [2021+, NOT REPORTABLE. FOR PRE-2021 USE CODE 8832/3.]"
8833/1,"Pigmented dermatofibrosarcoma protuberans (C44._) [2021+, NOT REPORTABLE. FOR PRE-2021 USE CODE 8833/3.]"
9591/1,"Monoclonal B-cell lymphocytosis, NOS [2021+]"
9673/1,In situ mantle cell neoplasia [2021+]
9680/1,EBV positive mucocutaneous ulcer [2021+]
9695/1,In situ follicular neoplasia [2021+]
9702/1,Indolent T-cell lymphoproliferative disorder of the gastrointestinal tract [2021+]
9709/1,Primary cutaneous CD4-positive small/medium T-cell lymphoproliferative disorder (C44._) [2021+ NOT REPORTABLE]
9715/3,"Anaplastic large cell lymphoma, ALK negative [2021+]"
9725/1,Hydroa vacciniforme-like lymphoproliferative disorder [2021 AND LATER NOT REPORTABLE. FOR PRE-2010 USE CODE 9725/3]
9749/3,Erdheim-Chester disease [2021+]
8509/3,Tall cell carcinoma with reversed polarity [2022+]
9761/1,IgM monoclonal gammopathy of undetermined significance [2021+]
9823/1,"Monoclonal B-cell lymphocytosis, CLL-type [2021+]"
9877/3,Acute myeloid leukemia with mutated NPM1 [2021+]
9878/3,Acute myeloid leukemia with biallelic mutation of CEBPA [2021+]
9879/3,Acute myeloid leukemia with mutated RUNX1 [2021+]
9968/3,Myeloid or lymphoid neoplasm with PCM1-JAK2 [2021+]
9993/3,Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia [2021+]
8524/2,Lobular carcinoma in situ mixed with other types of carcinoma
8730/2,Amelanotic melanoma in situ
8335/2,"Follicular carcinoma, in situ (C73.9)"
9200/3,"Osteoblastoma, malignant (C40._, C41._)"
8382/2,"Endometrioid adenocarcinoma in situ, secretory variant"
9321/3,Central odontogenic fibroma (C41._)
8163/2,"Papillary neoplasm, pancreatobiliary type, with high grade intraepithelial neoplasia (C24.1) [2022+]"
8483/2,"Adenocarcinoma in situ, HPV-associated (C53._) [2022+; NOT REPORTABLE]"
8484/2,"Adenocarcinoma in situ, HPV-independent, NOS (C53._) [2022+; NOT REPORTABLE]"
9050/2,Mesothelioma in situ [REPORTABLE 2023+]
9174/3,"Lymphangioleiomyomatosis [REPORTABLE 2023+. FOR PRE-2023, USE CODE 9174/1]"
9261/1,Osteofibrous dysplasia-like adamantinoma [2022+; NOT REPORTABLE]
9509/0,Multinodular and vacuolating neuronal tumor (MVNT) (C71.2) [2023+. FOR PRE-2023 USE 9505/0]
9509/3,Diffuse leptomeningeal glioneuronal tumor (C71._) [2023+]
9749/1,Juvenile xanthogranuloma (C71.5) [2023+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9222/1,Atypical cartilaginous tumor [2021+]
9222/3,"Chondrosarcoma, grade 1 (C40._, C41._) [REPORTABLE 2022+. FOR PRE-2022 USE CODE 9222/1]"
8144/2,"Intestinal-type adenoma, high grade (C16._, C17._) [REPORTABLE 2022+ FOR STOMACH AND SMALL INTESTINE ONLY; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABILITY.]"
8213/2,"Serrated dysplasia, high grade (C16._, C17._) [REPORTABLE 2022+ FOR STOMACH AND SMALL INTESTINE ONLY; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABILITY.]"
8455/2,"Intraductal oncocytic papillary neoplasm, NOS (C25._) [2022+]"
8455/3,Intraductal oncocytic papillary neoplasm with associated invasive carcinoma (C25._) [2022+]
8480/1,Low grade appendiceal mucinous neoplasm (LAMN) (C18.1) [2018-2021 NOT REPORTABLE; 2022+ USE 8480/2 PER STANDARD SETTERS SINCE TERM AND CORRESPONDING CODE NOT INCLUDED IN ICD-O-3.2; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABILITY]
8480/2,High grade appendiceal mucinous neoplasm (HAMN) (C181) [2022+]
8483/3,"Adenocarcinoma, HPV-associated (C53._) [2021+]"
8484/3,"Adenocarcinoma, HPV-independent, NOS (C53._) [2021+]"
8693/1,"Extra-adrenal paraganglioma, NOS [PRE-2021 ONLY. FOR 2021+ USE CODE 8693/3.]"
8693/3,"Extra-adrenal paraganglioma, NOS [REPORTABLE 2021+]"
8859/3,Myxoid pleomorphic liposarcoma [2022+]
8976/3,Gastroblastoma (C16._) [2022+]
9111/3,"Mesonephric-like adenocarcinoma (C54._, C56.9) [2022+]"
9174/1,"Lymphangiomyomatosis [PRE-2023, NOT REPORTABLE. FOR 2023+ USE CODE 9174/3]"
9366/3,Round cell sarcoma with EWSR1-non-ETS fusions [2022+]
9367/3,CIC-rearranged sarcoma [2022+]
9368/3,Sarcoma with BCOR genetic alterations [2022+]
9421/1,"Diffuse astrocytoma, MYB- or MYBL1-altered (C71._) [2023+]"
9421/3,High-grade astrocytoma with piloid features (HGAP) (C71._) [2023+]
9473/3,"Central primitive neuroectodermal tumor, NOS (C71._)"
9505/0,Multinodular and vacuolating neuronal tumor (MVNT) (C71.2) [FOR USE 2021-2022. FOR 2023+ USE 9509/0]
9738/1,HHV8-positive germinotropic-lymphoproliferative disorder
8361/1,Non-functioning juxtaglomerular cell tumor [2024+; NOT REPORTABLE]
8590/0,Myoid gonadal stromal tumor [2024+; NOT REPORTABLE]
9071/2,Intratubular yolk sac tumor [2024+]
9080/2,Intratubular teratoma [2024+]
9104/3,Placental site trophoblastic tumor of testis (C62._) [REPORTABLE FOR C62._ ONLY 2024+]
9080/3,"Teratoma, postpubertal-type [2024+]"
8023/3,Nuclear protein in testis (NUT)-associated carcinoma
8050/0,"Papilloma, NOS (except papilloma of bladder M-8120/1)"
8051/3,"Warty carcinoma [2018+ CASES FOR C60._, USE 8054/3. ALL OTHER SITES USE 8051/3 FOR ALL YEARS]"
8054/3,"Warty carcinoma (C60.0-C60.2, C60.9) [2018+. PRE-2018 CASES FOR C60, USE 8051/3. ALL OTHER SITES USE 8051/3 FOR ALL YEARS]"
8071/2,Differentiated penile [or vulvar] intraepithelial neoplasia (C60._ [or C51._]) [2018+ CASES ONLY]
8076/2,Squamous cell carcinoma in situ with questionable stromal invasion
8077/2,"Squamous intraepithelial neoplasia, grade III [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8091/3,Superficial basal cell carcinoma (C44._)
8098/3,Adenoid basal carcinoma (C53._)
8110/0,"Pilomatrixoma, NOS (C44._)"
8110/3,Pilomatrical carcinoma (C44._)
8122/3,"Urothelial carcinoma, sarcomatoid"
8130/1,Papillary urothelial neoplasm of low malignant potential (C67._)
8130/3,Papillary transitional cell carcinoma (C67._)
8131/3,"Urothelial carcinoma, micropapillary (C67._)"
8150/0,Pancreatic neuroendocrine microadenoma (C25._)
8150/1,"Pancreatic endocrine tumor, NOS (C25._) [PRE-2021 ONLY. FOR 2021+ USE CODE 8150/3.]"
8150/3,"Pancreatic neuroendocrine tumor, nonfunctioning (C25._) [REPORTABLE 2021+.]"
8151/0,"Insulinoma, NOS (C25._) [PRE-2021 ONLY. FOR 2021+ USE CODE 8151/3.]"
8151/3,"Insulinoma, NOS (C25._) [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8151/0]"
8152/1,"Glucagonoma, NOS (C25._) [PRE-2021 ONLY. FOR 2021+ USE CODE 8152/3.]"
8152/3,"Glucagonoma, NOS (C25._) [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8152/1]"
8153/1,"Gastrinoma, NOS [PRE-2021 ONLY. FOR 2021+ USE CODE 8153/3.]"
8153/3,"Gastrinoma, NOS [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8153/1]"
8154/3,"Mixed pancreatic endocrine and exocrine tumor, malignant (C25._)"
8155/1,"Vipoma, NOS [PRE-2021 ONLY. FOR 2021+ USE CODE 8155/3.]"
8155/3,"Vipoma, NOS [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8155/1.]"
8156/1,"Somatostatinoma, NOS [PRE-2021 ONLY. FOR 2021+ USE CODE 8156/3.]"
8156/3,"Somatostatinoma, NOS [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8156/1.]"
8158/1,ACTH-producing tumor [2018-2020 ONLY. FOR 2021+ USE CODE 8158/3.]
8161/0,"Bile duct cystadenoma (C22.1, C24.0)"
8161/3,"Bile duct cystadenocarcinoma (C22.1, C24.0)"
8162/3,"Klatskin tumor (C22.1, C24.0)"
8163/3,"Pancreatobiliary-type carcinoma (C24.1) [2018+. FOR 2015-2017, USE 8255/3]"
8213/0,Serrated adenoma (C18._)
8213/3,"Serrated adenocarcinoma (C18.0, C18.2, C18.9, C19.9, C20.9) [CODE FOR USE IN 2015+]"
8214/3,Parietal cell carcinoma (C16._)
8221/3,Adenocarcinoma in multiple adenomatous polyps
8230/2,"Ductal carcinoma in situ, solid type (C50._)"
8240/3,"Carcinoid tumor, NOS [including of appendix]"
8249/3,"Neuroendocrine tumor, grade 2"
8252/3,"Bronchiolo-alveolar carcinoma, non-mucinous (C34._)"
8253/2,"Adenocarcinoma in situ, mucinous (C34._) [LUNG ONLY, 2018+, DO NOT USE 8480]"
8253/3,"Invasive mucinous adenocarcinoma (C34._) [LUNG ONLY, 2018+, DO NOT USE 8480]"
8256/3,"Minimally invasive adenocarcinoma, non-mucinous (C34._) [2018+]"
8257/3,"Minimally invasive adenocarcinoma, mucinous (C34._) [2018+]"
8265/3,"Micropapillary carcinoma, NOS (C18._, C19.9, C20.9, C34._) [2018+ ONLY. FOR PRE-2018, USE 8507/3. FOR BREAST ALL YEARS, USE 8507/3.]"
8290/0,Oxyphilic adenoma
8290/3,Oxyphilic adenocarcinoma
8311/3,Hereditary leiomyomatosis and renal cell carcinoma (RCC- associated renal cell carcinoma) (C64.9) [2018+]
8312/3,"Renal cell carcinoma, NOS (C64.9)"
8313/1,Clear cell borderline tumor (C56.9)
8325/0,Metanephric adenoma (C64.9)
8330/0,"Follicular adenoma, NOS (C73.9)"
8330/3,"Follicular carcinoma, NOS (C73.9)"
8331/3,"Follicular adenocarcinoma, well differentiated (C73.9)"
8332/3,"Follicular adenocarcinoma, trabecular (C73.9)"
8333/3,Fetal adenocarcinoma (C73.9)
8337/3,Poorly differentiated thyroid carcinoma (C73.9) [2021+]
8339/3,"Follicular thyroid carcinoma (FTC), encapsulated angioinvasive (C73.9) [2018+]"
8342/3,"Papillary carcinoma, oncocytic variant (C73.9) [2021+]"
8343/2,Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) (C73.9) [REPORTABLE 2017-2020 ONLY. FOR 2021+ USE CODE 8349/1.]
8345/3,Medullary carcinoma (C73.9) [FOR THYROID 2018+. FOR BREAST FOR ALL YEARS USE 8510.]
8361/0,Juxtaglomerular tumor (C64.9)
8380/3,"Endometrioid adenocarcinoma, NOS"
8390/3,Adnexal adenocarcinoma (C44. _)
8402/3,Hidradenocarcinoma (C44. _)
8407/3,Microcystic adnexal carcinoma (C44. _)
8408/1,Aggressive digital papillary adenoma (C44._) [PRE-2021 NOT REPORTABLE;FOR 2021+ USE CODE 8408/3.]
8408/3,Digital papillary adenocarcinoma (C44. _)
8409/3,Porocarcinoma (C44._)
8410/3,Sebaceous carcinoma (C44._)
8441/2,"Serous endometrial [tubal] intraepithelial carcinoma (C54._, C55.9 [C57.0])"
8441/3,"Serous carcinoma, NOS"
8452/1,Solid pseudopapillary tumor of ovary (C56.9)
8452/3,Solid pseudopapillary neoplasm of the pancreas (C25._) [REPORTABLE 2021+]
8460/2,Non-invasive low grade serous carcinoma (C56.9)
8460/3,"Low-grade serous carcinoma (C56.9, C48._, C57.0, C57.1-C57.3)"
8461/3,"High-grade serous carcinoma (C48._, C56.9, C57.0, C57.1-C57.3)"
8462/1,Serous papillary cystic tumor of borderline malignancy (C56.9)
8470/0,"Mucinous cystadenoma, NOS (C56.9)"
8470/2,Mucinous cystic neoplasm with high grade dysplasia (C25. _)
8471/3,Papillary mucinous cystadenocarcinoma (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8470/3.]
8473/1,"Papillary mucinous cystadenoma, borderline malignancy (C56.9) [obs] [PRE-2021 ONLY. FOR 2021+, USE CODE 8472/1]"
8474/3,Seromucinous carcinoma (C56.9) [2018+]
8480/3,Mucinous adenocarcinoma [2018+: USE 8253 FOR LUNG ONLY]
8500/3,Invasive carcinoma of no special type (C50._) [BREAST ONLY]
8504/2,Encapsulated papillary carcinoma C50._)
8504/3,Encapsulated papillary carcinoma with invasion (C50._)
8506/0,Adenoma of nipple (C50.0)
8507/3,Invasive micropapillary carcinoma (C50._) [USE FOR C50._ FOR ALL YEARS. FOR ALL OTHER SITES USE 8265/3 FOR 2018+ AND USE 8507/3 FOR PRE-2018.]
8508/3,Cystic hypersecretory carcinoma (C50._) [PRE-2021 ONLY. FOR 2021+ USE CODE 8500/2.]
8509/2,Solid papillary carcinoma in situ (C50._) [2018+]
8510/3,"Medullary carcinoma, NOS [DO NOT USE FOR THYROID 2018+, USE 8345/3.]"
8519/2,Pleomorphic lobular carcinoma in situ (C50._) [2018+. IF INVASIVE USE CODE 8520/3]
8520/2,"Lobular carcinoma in situ, NOS (C50._)"
8522/2,Intraductal carcinoma and lobular carcinoma in situ (C50._)
8541/3,Paget disease and infiltrating duct carcinoma of breast (C50._)
8543/3,Paget disease and intraductal carcinoma of breast (C50._)
8552/3,"Mixed acinar ductal carcinoma [2018+. FOR PRE-2018, USE CODE 8523/3]"
8580/1,"Thymoma, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8580/3.]"
8580/3,"Thymoma, NOS (C37.9) [2021+]"
8581/1,"Thymoma, type A, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8581/3.]"
8581/3,"Thymoma, type A, NOS (C37.9) [2021+]"
8582/1,"Thymoma, type AB, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8582/3.]"
8582/3,"Thymoma, type AB, NOS (C37.9) [2021+]"
8583/1,"Thymoma, type B1, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8583/3.]"
8583/3,"Thymoma, type B1, NOS (C37.9) [2021+]"
8584/1,"Thymoma, type B2, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8584/3.]"
8584/3,"Thymoma, type B2, NOS (C37.9) [2021+]"
8585/1,"Thymoma, type B3, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8585/3.]"
8585/3,"Thymoma, type B3, NOS (C37.9) [2021+]"
8589/3,Intrathyroid thymic carcinoma (C73.9) [2021+]
8620/1,"Granulosa cell tumor, adult type (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8620/3.]"
8620/3,Adult granulosa cell tumor (C56.9 ONLY) [2018+ CASES ONLY;NOT REPORTABLE. REPORTABLE 2021+]
8680/1,"Paraganglioma, NOS [PRE-2021 ONLY. FOR 2021+ USE CODE 8680/3.]"
8680/3,"Paraganglioma, NOS [REPORTABLE 2021+]"
8681/1,Sympathetic paraganglioma [PRE-2021 ONLY. FOR 2021+ USE CODE 8681/3.]
8682/1,Parasympathetic paraganglioma [PRE-2021 ONLY. FOR 2021+ USE CODE 8682/3.]
8690/1,"Glomus jugulare tumor, NOS (C75.5) [PRE-2021 ONLY. FOR 2021+ USE CODE 8690/3.]"
8690/3,"Middle ear paraganglioma (C30.1, C75.5) [REPORTABLE 2021+]"
8691/1,Aortic body tumor (C75.5) [PRE-2021 ONLY. FOR 2021+ USE CODE 8691/3.]
8691/3,Aortic body tumor (C75.5) [REPORTABLE 2021+]
8692/1,Carotid body tumor (C75.4) [PRE-2021 ONLY. FOR 2021+ USE CODE 8692/3.]
8692/3,Carotid body paraganglioma (C75.4) [REPORTABLE 2021+]
8700/0,"Pheochromocytoma, NOS (C74.1) [PRE-2021 ONLY. FOR 2021+ USE CODE 8700/3.]"
8700/3,"Pheochromocytoma, NOS (C74.1) [REPORTABLE 2021+]"
8714/3,"PEComa, malignant [2018+]"
8720/3,"Malignant melanoma, NOS (except juvenile melanoma M-8770/0)"
8728/3,Meningeal melanomatosis (C70.9)
8743/3,Low cumulative sun damaged melanoma (C44. _) [2021+]
8744/3,Acral melanoma (C44. _)
8761/3,Malignant melanoma arising in giant congenital nevus (C44. _) [2021+]
8770/3,Malignant Spitz tumor (C44. _) [2021+]
8802/3,Giant cell sarcoma (except of bone M-9250/3)
8811/1,Myxoinflammatory fibroblastic sarcoma (MIFS) (C49._) [NOT REPORTABLE]
8811/3,Myxofibrosarcoma
8815/1,Solitary fibrous tumor/hemangiopericytoma Grade 2 (CNS) (C71._) [2018+] [REPORTABLE FOR CNS]
8823/0,Desmoplastic fibroma
8832/3,"Dermatofibrosarcoma protuberans, fibrosarcomatous"
8833/3,Pigmented dermatofibrosarcoma protuberans (C44._) [REPORTABLE PRE-2021 ONLY. FOR 2021+ USE CODE 8833/1.]
8842/3,"Ossifying fibromyxoid tumor, malignant (C49._)"
8905/0,"Genital rhabdomyoma (C51._, C52.9)"
8931/3,"Endometrial stromal sarcoma, low grade (C54.1)"
8936/1,"Gastrointestinal stromal tumor, NOS [PRE-2021 ONLY. FOR 2021+ USE CODE 8936/3.]"
8936/3,"Gastrointestinal stromal tumor, NOS [REPORTABLE 2021+]"
8959/0,Benign cystic nephroma (C64.9)
8959/1,Cystic partially differentiated nephroblastoma (C64.9)
8959/3,Malignant cystic nephroma (C64.9)
8960/3,"Nephroblastoma, NOS (C64.9)"
8963/3,"Rhabdoid tumor, NOS"
8964/3,Clear cell sarcoma of kidney (C64.9)
8965/0,"Nephrogenic adenofibroma (C64.9) [obs] [PRE-2021 ONLY. FOR 2021+, USE CODE 9013/0.]"
8966/0,Renomedullary interstitial cell tumor (C64.9)
8967/0,Ossifying renal tumor (C64.9)
8971/3,Pancreatoblastoma (C25._)
8982/3,Myoepithelial carcinoma
9044/3,Clear cell sarcoma (except of kidney M-8964/3)
9045/3,"Biphenotypic sinonasal sarcoma (C30.0, C31.0-C31.3, C31.8, C31.9) [2018+]"
9086/3,Germ cell tumors with associated hematological malignancy (C37.9) [2018+]
9191/0,"Osteoid osteoma, NOS (C40._, C41._)"
9220/0,"Chondroma, NOS (C40._, C41._)"
9260/3,"Ewing sarcoma (C40._, C41._) [USE FOR PRE-2021. FOR 2021+ USE 9364/3]"
9310/3,"Ameloblastoma, metastasizing [2021+]"
9352/1,"Craniopharyngioma, papillary (C75.2)"
9361/3,Papillary tumor of the pineal region [USE FOR 2015-2017. FOR 2018+ USE 9395/3]
9363/0,Melanotic neuroectodermal tumor
9364/3,"Ewing sarcoma (C40._, C41._) [2021+. FOR PRE-2021 USE 9260/3]"
9380/1,Angiocentric glioma [USE FOR 2015-2017. FOR 2018+ USE 9431/1]
9384/1,Subependymal giant cell astrocytoma (C71._)
9385/3,"Diffuse midline glioma, H3 K27M-mutant (C71._) [2018+]"
9390/3,Choroid plexus carcinoma (C71.5)
9393/3,Papillary ependymoma (C71._)
9394/1,Myxopapillary ependymoma (C72.0)
9395/3,Papillary tumor of pineal region (C75.3) [2018+. FOR PRE-2018 USE 9361/3]
9396/3,"Ependymoma, RELA fusion-positive (C71._) [2018+]"
9425/3,Pilomyxoid astrocytoma (C71._) [2018+. FOR PRE-2018 USE 9421/3]
9431/1,Angiocentric glioma [2018+. FOR PRE-2018 USE 9380/1]
9432/1,Pituicytoma (C75.1) [2018+. FOR PRE-2018 USE 9380/1]
9445/3,"Glioblastoma, IDH-mutant (C71._) [2018+]"
9460/3,Oligodendroblastoma (C71._) [obs]
9475/3,"Medulloblastoma, WNT-activated (C71._) [2018+]"
9476/3,"Medulloblastoma, SHH-activated and TP53 mutant (C71._) [2018+]"
9477/3,"Medulloblastoma, non-WNT/non-SHH (C71._) [2018+]"
9478/3,"Embryonal tumor with multilayered rosettes, NOS (C71._) [2018+]"
9493/0,Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos) (C71.6)
9502/3,Teratoid medulloepithelioma (C69.4)
9508/3,Embryonal tumor with rhabdoid features (C71._)
9509/1,Papillary glioneuronal tumor (C71._) [2018+. FOR PRE-2018 USE 9505/1]
9531/0,Meningothelial meningioma (C70._)
9539/1,Atypical meningioma (C70._)
9540/1,"Neurofibromatosis, NOS [REMOVED FROM ICD-O-3.2;NOT REPORTABLE 2018+]"
9542/3,"Epithelioid malignant peripheral nerve sheath tumor (C47.0-C47.6, C47.8, C47.9) [2018+]"
9550/0,Plexiform neurofibroma
9560/1,Neurinomatosis
9563/0,"Nerve sheath tumor, NOS [2021+]"
9571/0,"Perineurioma, NOS"
9582/0,Granular cell tumor of the sellar region (C75.1)
9591/3,"Malignant lymphoma, non-Hodgkin, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9596/3,Composite Hodgkin and non-Hodgkin lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9597/3,Primary cutaneous follicle centre lymphoma [2010+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9650/3,Classical Hodgkin lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9651/3,"Hodgkin lymphoma, lymphocyte-rich [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9652/3,"Hodgkin lymphoma, mixed cellularity, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9653/3,"Hodgkin lymphoma, lymphocyte depletion, NOS [2010+. FOR PRE-2010 USE CODE 9654/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9654/3,"Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis [obs] [PRE-2010 ONLY. FOR 2010+ USE CODE 9653/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9655/3,"Hodgkin lymphoma, lymphocyte depletion, reticular [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9659/3,"Hodgkin lymphoma, nodular lymphocyte predominance [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9661/3,Hodgkin granuloma [obs] [PRE-2010 ONLY. FOR 2010+ USE CODE 9650/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9662/3,Hodgkin sarcoma [obs] [PRE-2010 ONLY. FOR 2010+ USE CODE 9650/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9663/3,Nodular sclerosis classical Hodgkin lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9664/3,"Hodgkin lymphoma, nodular sclerosis, cellular phase [PRE-2010 ONLY. FOR 2010+ USE CODE 9663/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9665/3,"Hodgkin lymphoma, nodular sclerosis, grade 1 [PRE-2010 ONLY. FOR 2010+ USE CODE 9663/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9667/3,"Hodgkin lymphoma, nodular sclerosis, grade 2 [PRE-2010 ONLY. FOR 2010+ USE CODE 9663/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670/3,"Malignant lymphoma, small B lymphocytic, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9671/3,"Malignant lymphoma, lymphoplasmacytic (see also M-9761/3) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9673/3,"Mantle cell lymphoma (includes all variants: blastic, pleomorphic, small cell) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9675/3,"Malignant lymphoma, mixed small and large cell, diffuse [PRE-2010 ONLY. FOR 2010+ USE CODE 9690/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9679/3,Mediastinal large B-cell lymphoma (C38.3) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9680/3,"Diffuse large B-cell lymphoma, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9684/3,"Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS D5425 [PRE-2010 ONLY. FOR 2010+ USE CODE 9680/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687/3,"Burkitt lymphoma, NOS (includes all variants) (see also M-9826/3) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9688/3,T cell/histiocyte rich large B-cell lymphoma [2010+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9689/3,Splenic marginal zone B-cell lymphoma (C42.2) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9690/3,"Follicular lymphoma, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9701/3,Sezary syndrome [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9702/3,"Mature T-cell lymphoma, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9708/3,Subcutaneous panniculitis-like T-cell lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9709/3,"Cutaneous T-cell lymphoma, NOS (C44._) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9712/3,Intravascular large B-cell lymphoma [2010+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9714/3,"Anaplastic large cell lymphoma, T-cell and Null cell type [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9716/3,Hepatosplenic gamma-delta cell lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9717/3,Intestinal T-cell lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9718/1,Primary cutaneous CD30+ T-cell lymphoproliferative disorder (C44._) [2021+ NOT REPORTABLE;FOR PRE-2021 USE CODE 9718/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9718/3,Primary cutaneous anaplastic large cell lymphoma (C44._) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9719/3,"NK/T-cell lymphoma, nasal and nasal-type [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9724/3,Systemic EBV-positive T-cell lymphoproliferative disease of childhood [2010+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9725/3,Hydroa vacciniforme-like lymphoproliferative disorder [REPORTABLE 2010 - 2020 ONLY. FOR 2021+ USE CODE 9725/1;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9726/3,Primary cutaneous gamma delta T-cell lymphoma [2010+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9727/3,"Precursor cell lymphoblastic lymphoma, NOS (see also M-9835/3) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9728/3,Precursor B-cell lymphoblastic lymphoma [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9729/3,"Precursor T-cell lymphoblastic lymphoma, NOS B lymphoblastic [PRE-2010 ONLY. FOR 2010+ USE CODE 9837/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9731/3,"Plasmacytoma, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9732/3,Plasma cell myeloma [2010+. FOR PRE-2010 USE CODE 9733/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9733/3,Plasma cell leukemia [PRE-2010 ONLY. FOR 2010+ USE CODE 9832/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9734/3,"Plasmacytoma, extramedullary (not occurring in bone) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9735/3,Plasmablastic lymphoma [2010+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9737/3,ALK-positive large B-cell lymphoma [2010+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9738/3,HHV8-positive diffuse large B-cell lymphoma [2010+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9740/1,"Mastocytoma, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9741/3,Malignant mastocytosis [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9750/3,Malignant histiocytosis [PRE-2010 ONLY. FOR 2010+ USE CODE 9651/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9751/1,"Langerhans cell histiocytosis, NOS [NOT REPORTABLE 2021+. FOR 2010 - 2020 USE CODE 9751/3. FOR PRE-2010 USE CODE 9750/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751/3,"Langerhans cell histiocytosis, disseminated [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9752/1,"Langerhans cell histiocytosis, unifocal [obs] [PRE-2010 NOT REPORTABLE. FOR 2010+ USE CODE 9751/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9754/3,"Langerhans cell histiocytosis, disseminated [obs] [FOR 1978-2009 ONLY. FOR 2010+ USE CODE 9751/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9759/3,Fibroblastic reticular cell tumor [2010+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9760/3,"Immunoproliferative disease, NOS [PRE-2010 ONLY. FOR 2010+ SEE CODES 9761/3 AND 9762/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9761/3,Waldenstrom macroglobulinemia [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9764/3,Immunoproliferative small intestinal disease (C17._) [PRE-2010 ONLY. FOR 2010+ USE CODE 9762/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9766/3,"Lymphomatoid granulomatosis, grade 3 [2021+;FOR PRE-2021 USE CODE 9680/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9767/1,Angioimmunoblastic lymphadenopathy (AIL) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9768/1,T-gamma lymphoproliferative disease [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9801/3,"Acute leukemia, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9805/3,Acute biphenotypic leukemia (C42.1) [PRE 2010 ONLY. FOR 2010+ USE CODES 9806 - 9809;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9806/3,Mixed phenotype acute leukemia with t(9;22)(q34;q11.2);BCR-ABL1 [2010 AND LATER ONL. FOR PRE 2010 USE CODE 9805/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9807/3,Mixed phenotype acute leukemia with t(v;11q23);MLL rearranged [2010+. FOR PRE 2010 USE CODE 9805/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9808/3,"Mixed phenotype acute leukemia, B/myeloid, NOS [2010+. FOR PRE 2010 USE CODE 9805/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9809/3,"Mixed phenotype acute leukemia, T/myeloid, NOS [2010+. FOR PRE 2010 USE CODE 9805/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811/3,"B lymphoblastic leukemia/lymphoma, NOS [2010+. FOR PRE 2010 USE CODE 9728/3, 9835/3, OR 9836/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9812/3,B lymphoblastic leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1 [2010+. FOR PRE 2010 USE CODE 9835/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9813/3,B lymphoblastic leukemia/lymphoma with t(v;11q23);MLL rearranged [2010+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9814/3,B lymphoblastic leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1 (ETV6-RUNX1) [2010+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9815/3,B lymphoblastic leukemia/lymphoma with hyperdiploidy [2010+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9816/3,B lymphoblastic leukemia/lymphoma with hypodiploidy (hypodiploid ALL) [2010+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9817/3,B lymphoblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH [2010+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9818/3,B lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3);E2A PBX1 (TCF3 PBX1) [2010+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9819/3,"B lymphoblastic leukemia/lymphoma, BCR-ABL1-like [2021+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9823/3,Chronic lymphocytic leukemia/small lymphocytic lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9826/3,"Burkitt cell leukemia (C42.1) [PRE-2021 ONLY. 2021+, USE CODE 9687/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9827/3,Adult T-cell leukemia/lymphoma (HTLV-1 positive) (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9831/3,T-cell large granular lymphocytic leukemia (C42.1) [REPORTABLE 2010+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9833/3,"Prolymphocytic leukemia, B-cell type (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9834/3,"Prolymphocytic leukemia, T-cell type (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835/3,"Precursor cell lymphoblastic leukemia, NOS (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9836/3,Precursor B-cell lymphoblastic leukemia (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9837/3,T lymphoblastic leukemia/lymphoma [2010+. FOR PRE 2010 USE CODE 9729/3;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9865/3,Acute myeloid leukemia with t(6;9)(p23;q34);DEK-NUP214 [2010+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9866/3,"Acute promyelocytic leukemia, t(15;17)(q22;q11-12) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9869/3,Acute myeloid leukemia with inv(3)(q21;q26.2) or t(3;3)(q21p26.2);RPN1-EVI1 [2010+. SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9871/3,Acute myeloid leukemia with abnormal marrow eosinophils (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9872/3,"Acute myeloid leukemia, minimal differentiation (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9874/3,Acute myeloid leukemia with maturation (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9875/3,"Chronic myelogenous leukemia, BCR/ABL positive (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9876/3,"Atypical chronic myeloid leukemia, BCR/ABL negative (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9891/3,Acute monocytic leukemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9895/3,Acute myeloid leukemia with multilineage dysplasia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9896/3,"Acute myeloid leukemia, t(8;21)(q22;q22) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9897/3,"Acute myeloid leukemia, 11q23 abnormalities (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9898/3,Myeloid leukemia associated with Down Syndrome [2010+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9911/3,Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13);RBM15-MKL1 [2010+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9912/3,Acute myeloid leukemia with BCR-ABL1 [2021+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9920/3,Therapy-related myeloid neoplasm (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9945/3,"Chronic myelomonocytic leukemia, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9960/3,"Chronic myeloproliferative disease, NOS (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9975/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9961/3,Myelosclerosis with myeloid metaplasia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9964/3,Hypereosinophilic syndrome (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9965/3,Myeloid and lymphoid neoplasms with PDGFRA rearrangement [2010+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9966/3,Myeloid neoplasms with PDGFRB rearrangement [2010+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9967/3,Myeloid and lymphoid neoplasm with FGFR1 abnormalities [2010+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9970/1,"Lymphoproliferative disorder, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9971/1,"Post Transplant Lymphoproliferative Disorder, NOS (PTLD) [2021+ NOT REPORTABLE. SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9971/3,Polymorphic Post Transplant Lymphoproliferative Disorder (PTLD) [REPORTABLE 2010 - 2020 ONLY. SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9975/3,"Myelodysplastic/Myeloproliferative neoplasm, unclassifiable [REPORTABLE 2010+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9980/3,Myelodysplastic syndrome with single lineage dysplasia [2021+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9982/3,Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia [2021+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9983/3,Myelodysplastic syndrome with excess blasts [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9984/3,Refractory anemia with excess blasts in transformation (C42.1) [obs] [FOR PRE-2010 ONLY. FOR 2010+ USE CODE 9983/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9985/3,Myelodysplastic syndrome with multilineage dysplasia [2021+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9986/3,Myelodysplastic syndrome with isolated del (5q) [2021+;SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9987/3,"Therapy-related myelodysplastic syndrome, NOS (C42.1) [FOR PRE-2010 ONLY. FOR 2010+ USE CODE 9920/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9989/3,"Myelodysplastic syndrome, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9991/3,"Refractory neutropenia [FOR 2010 - 2020 ONLY. 2021+, USE CODE 9980/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9992/3,"Refractory thrombocytopenia [FOR 2010 - 2020 ONLY. 2021+, USE CODE 9980/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
8550/3,"Acinar cell carcinoma [EXCLUDES C61.9, USE 8140/3 FOR PROSTATE]"
9351/1,"Craniopharyngioma, adamantinomatous (C75.2)"
8104/0,Pilar sheath acanthoma (C44._) [2021+]
8348/1,Well differentiated tumor of uncertain malignant potential (C73.9) [2021+]
8444/1,Clear cell cystic tumor of borderline malignancy (C56.9) [obs] [PRE-2021 ONLY. FOR 2021+ USE CODE 8313/1.]
8563/0,Lymphadenoma [2021+]
8643/1,Intratubular large cell hyalinizing Sertoli cell neoplasia [2021+]
8816/0,Calcifying aponeurotic fibroma [2021+]
8817/0,Calcifying fibrous tumor [2021+]
8818/0,Fibrous dysplasia [2021+]
8992/0,Pulmonary hamartoma (C34._) [2021+]
9211/0,Osteochondromyxoma [2021+]
9212/0,Bizarre parosteal osteochondromatous proliferation [2021+]
9213/0,Subungual exostosis [2021+]
9753/1,"Langerhans cell histiocytosis, multifocal [obs] [PRE-2010 NOT REPORTABLE. FOR 2010+ USE CODE 9751/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9810/3,Compound leukemia [obs] [FOR 1978-1991 ONLY. FOR 1992+ USE CODE 9800/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
8043/3,"Small cell carcinoma, fusiform cell"
8045/3,Combined small cell carcinoma
8140/0,"Adenoma, NOS"
8140/1,Atypical adenoma
8201/3,"Cribriform carcinoma, NOS"
8240/1,Carcinoid tumor of uncertain malignant potential
8500/2,"Intraductal carcinoma, noninfiltrating, NOS"
8800/3,"Sarcoma, NOS"
8940/3,"Mixed tumor, malignant, NO"
8951/3,Mesodermal mixed tumor
8990/0,"Mesenchymoma, benign"
8990/1,"Mesenchymoma, NOS"
8990/3,"Mesenchymoma, malignant"
8727/0,Dysplastic nevus (C44._)
8442/2,Proliferating serous carcinoma in situ (C56.9) ([obs]- see 8441/2)
8442/3,Papillary serous carcinoma malignant ([obs]- see 8441/3)
8252/2,"Bronchio-alveolar carcinoma, non-mucinous in situ (C34._) [PRE-2018 ONLY. FOR 2018+ USE CODE 8250/2]"
8290/2,Oxyphilic adenocarcinoma in situ (C73.9)
8890/1,"Leiomyomatosis, NOS (C54._, C55.9)"
8841/0,Angiomyxoma (C49._)
8336/1,Hyalinizing trabecular adenoma (C73.9)
8680/0,"Paraganglioma, benign (C47.9, C75.4, C75.5)"
